Friday, June 11, 12:00p EDT
Panelists Melissa Creary and Liza Johnson will describe the current state of therapy for sickle cell disease, and some ethical issues that arise in the emerging use of gene transfer or gene editing for treating the disease. Dr. Johnson will focus on ethical issues identified by patients, and Dr. Creary will discuss some of the social and historical ethical challenges that relate to genetic interventions for sickle cell.
Follow this link to register.